Summary: Affimed’s 06/01/24 update on AFM24 means the company has a second viable commercial asset.
Iryna Drozd Affimed (NASDAQ:AFMD) said it has received fast track designation from the FDA for
Affimed press release (NASDAQ:AFMD): FY GAAP EPS of -€7.09. Revenue of €8.28M (-80.0% Y/Y). As of
studiostockart Affimed N.V. (NASDAQ:AFMD) dropped ~21% premarket Wednesday after the German biotech announced a 1-for-10
Adam Gault/OJO Images via Getty Images Immuno-oncology company Affimed (NASDAQ:AFMD) said on Monday that CEO
Design Cells Immuno-oncology company Affimed (NASDAQ:AFMD) announced on Wednesday a deal to sell its wholly-owned
Dr_Microbe/iStock via Getty Images Affimed (NASDAQ:AFMD) shares erased gains despite reporting encouraging data on its
pcess609 Affimed N.V. (NASDAQ:AFMD) shares lost ~13% on Thursday after the German biotech announced that
Summary: Affimed’s cash and cash equivalents stand at $166.7 million, sufficient to support operations until
Summary: Affimed has decided to focus on testing AFM13 in combination with Artiva’s AB-101 NK